Literature DB >> 3014066

Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor.

A P Mizisin, H C Powell, R R Myers.   

Abstract

Galactose neuropathy was produced in rats by feeding a diet containing 30% D-galactose. After 12 weeks of galactose ingestion, all rats developed bilateral cataracts, polydypsia and polyuria. These galactose-intoxicated animals were divided into two groups that both continued with the galactose diet: animals that were treated with the aldose reductase inhibitor, ICI 128,436, for 4-6 weeks, and a control group of animals that received just excipient. At the end of the study, endoneurial fluid pressures, nerve water contents and endoneurial fluid electrolyte concentrations were determined from sciatic nerves of treated and untreated animals. The extent of neuropathy in each animal was evaluated by light microscopy. Treatment of galactose-intoxicated rats with ICI 128,436 restored to normal levels the elevated endoneurial sodium concentration, increased water content and interstitial fluid pressure characteristic of galactose neuropathy. These results, obtained with an agent that blocks the sorbitol pathway, associate elevated sodium with an osmotic force contributing to edema and increased endoneurial fluid pressure in galactose neuropathy and suggest that endoneurial sodium levels are linked to blood-sugar concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014066     DOI: 10.1016/0022-510x(86)90189-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Freeze-fracture observations on normal and abnormal human perineurial tight junctions: alterations in diabetic polyneuropathy.

Authors:  N G Beamish; C Stolinski; P K Thomas; R H King
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.

Authors:  L B Dahlin; D R Archer; W G McLean
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

Review 3.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

4.  Fine-structural localization of aldose reductase and ouabain-sensitive, K(+)-dependent p-nitro-phenylphosphatase in rat peripheral nerve.

Authors:  H C Powell; R S Garrett; P F Kador; A P Mizisin
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Opposite effects of diabetes and galactosaemia on adenosine triphosphatase activity in rat nervous tissue.

Authors:  J E Lambourne; D R Tomlinson; A M Brown; G B Willars
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

Review 6.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

7.  In vivo study of brain metabolism in galactosemia by 1H and 31P magnetic resonance spectroscopy.

Authors:  H E Möller; K Ullrich; P Vermathen; G Schuierer; H G Koch
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 8.  Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult.

Authors:  Andrew P Mizisin; Ananda Weerasuriya
Journal:  Acta Neuropathol       Date:  2010-12-07       Impact factor: 17.088

Review 9.  Current and Future Treatments for Classic Galactosemia.

Authors:  Britt Delnoy; Ana I Coelho; Maria Estela Rubio-Gozalbo
Journal:  J Pers Med       Date:  2021-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.